Alerting Members To VXRT Ahead of 42% Gain
by Mike Paulenoff
January 30, 2021 • 12:00 AM EST
This past Monday, after Vaxart, Inc. (VXRT) popped above key technical resistance, Mike Paulenoff posted a timely update alerting MPTrader members to a potentially significant upside breakout:
"VXRT has again climbed into heavy, but very consequential resistance from 8.30 to 9.45," Mike wrote. "If VXRT can chew through the resistance zone, it will be poised for upside continuation that projects 14-15 in a 'normal' market. We all know that once these Covid-related names gain traction, they are anything but normal. VXRT is in Phase 1 Trials testing its oral (pill form) Covid vaccine drug."
VXRT was trading at 8.44 at the time, and two hours later the stock was at 10.56, taking out all resistance since mid-August -- and still on no news.
Mike wrote: "In the absence of company or drug product news, I am thinking that just maybe VXRT's 35% short interest is what is attracting buyers to the name, which seems to be the new game in town... I am just guessing that perhaps that is one reason it is flying, but I am also hearing that the ARK Innovation Fund bought VXRT at 8.10 this AM-- you know, the folks who bought TSLA, and ROKU, etc, which certainly has some coattails."
Mike continued to closely monitor and post chart updates on VXRT for MPTrader members throughout the week, with the stock reaching as high as 13.50 on Friday before closing the week at 11.98, up 42% above its price at Mike's alert on Monday.
What next for VXRT in this upcoming week when the company is expected to release data from its Phase 1 Covid Vaccine Trial, and from earnings?
Join Mike and our MPTrader members as they closely monitor the trading and pattern development of VXRT, as well as many other individual stocks, sector ETFs, macro indices, and precious metals.
On November 8, just after TSLA (Tesla Inc) traded down a new multi-month corrective low at 185.75, Mike Paulenoff posted the following analysis to the MPTrader member discussion room:TSLA is getting closer to BOTH my next optimal downside target zone of 170-175 AND a condition of downside exhaustion within the downleg from the 8/16 high at 314.67.Bottom Line: As of this moment, TSLAs plunge today to a new big picture corrective low at 186.
On Wed Nov 9, the day before the next consequential CPI (inflation) report, Mike Paulenoff posted the following bullish analysis of the TLT (20+ Year T-bond ETF) for MPTrader members, writing:If my attached 4 Hour TLT (20+ Year T-bond ETF) Chart Setup is whispering anything to us about the next likely near-term directional price surge, then all of the action since mid-October has carved out an accumulation pattern in the form of a big W that has the potential to trigger a sharp
On September 30, 2022, Mike Paulenoff posted the following currency and precious metals commentary to our discussion room at MPTrader:The Dollar and the PM Miners-- I can make a compelling technical argument that this weeks major downside reversal in the US Dollar Index (DXY) from a multi-decade high at 114.78 to todays low at 111.
Last Monday (Oct 31), Mike Paulenoff posted the following analysis of F (Ford) for our MPTrader members:F (Ford) arguably has been in a bear-correction phase for all of 2022. However, one look at my attached 4-Hour Chart certainly makes me wonder if the May-October portion of 2022 represents a budding accumulation period and pattern ahead of a potentially powerful upside breakout heading into 2023.I dont have the answer yet, BUT my rally pattern setup off of BOTH the May 17 and the Oct.
Back on August 29, Mike Paulenoff alerted MPTrader members to his excitement about the potential for a powerful advance in Gilead Sciences (GILD), writing:
For two years, GILD has been traversing a wide (24%) range between 57-59 on the low side and 70-72 on the high side (see my attached Daily Chart). Every time GILD sinks into the vicinity of 60, it becomes relatively cheap within the range (57 stop) ahead of a traverse towards 70-72...
